November 19, 2024

Predicting ICH Causes: MRI Advantage

Conexiant

November 19, 2024

Gantenerumab Linked to ARIA Risk in Early Alzheimer's Disease

86% of ARIA-E cases occurred within the first 64 weeks of gantenerumab treatment, with APOE ε4 homozygotes showing nearly 5-fold increased risk.

Conexiant

November 19, 2024

Analysis Maps Broad Semaglutide Eligibility

An estimated 136.8 million U.S. adults are eligible for semaglutide, a number exceeding current eligibility for statins, according to an analysis.

Conexiant

November 19, 2024

Novel Stroke Drug Shows 12-Hour Window

Despite a median treatment time of 9.5 hours after stroke onset - more than twice the current therapeutic window - JX10 showed significantly better functional outcomes than placebo with no symptomatic intracranial hemorrhage events.

Conexiant

November 19, 2024

Art-Based Training Improves Neurology Observational Skills

Conexiant

November 18, 2024

Skin Disease Signals Hidden Heart Risks

Psoriasis not only marks the skin but also significantly raises the risk of myocardial infarction, stroke, and cardiovascular death, highlighting an urgent need for cardiovascular screening in these patients.

Conexiant

November 18, 2024

RFK Jr. Calls Fluoride 'Industrial Waste'

"On January 20, the Trump White House will advise all U.S. water systems to remove fluoride from public water."

KFF Health News

November 18, 2024

Revised AF Guidelines for Dialysis Patients

"The components of the CHA2DS2-VASc score are so prevalent in HD patients with AF that most qualify for OAC if the guidelines are applied" - an observation from the study that challenges conventional risk assessment approaches for this high-risk population.

Conexiant

November 18, 2024

Partial Cardiac Denervation and Postoperative Atrial Fibrillation Risk

Conexiant